Henry Hallett Dale, 1875–1968

  • H. O. Schild
Conference paper
Part of the Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie book series (ERGEBPHYSIOL, volume 63)


Nerve Ending Active Principle Ergot Alkaloid Nerve Impulse Presidential Address 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1900. Dale, H. H.: On some numerical comparisons of the centripetal and centrifugal medullated nerve-fibres arising in the spinal ganglia of the mammal. J. Physiol. (Lond.) 25, 196.PubMedGoogle Scholar
  2. 1901. —Galvanotaxis and chemotaxis of ciliate infusoria. J. Physiol. (Lond.) 26, 291.PubMedGoogle Scholar
  3. — Observations, chiefly by the degeneration method, on possible efferent fibres in the dorsal nerve-roots of the toad and frog. J. Physiol. (Lond.) 27, 250.Google Scholar
  4. 1904. —The Islets of Langerhans of the pancreas. (Abstr.) Proc. roy. Soc. 73, 84. On the “Islets of Langerhans” in the pancreas. Phil. Trans. B 197, 25.Google Scholar
  5. 1905. Bainbridge, F. A., Dale, H. H.: The contractile mechanism of the gall-bladder and its extrinsic nervous control. J. Physiol. (Lond.) 33, 138.PubMedGoogle Scholar
  6. Dale, H. H.: The physiological action of chrysotoxin. (Prel. Com.) J. Physiol. (Lond.) 32, 58P.Google Scholar
  7. 1906. Barger, G., Dale, H. H.: Die Mutterkornalkaloide. Arch. Pharm. (Weinheim) 244, 550.Google Scholar
  8. Dale, H. H.: On some physiological actions of ergot. J. Physiol. (Lond.) 34, 163.Google Scholar
  9. 1907. Barger, G., Dale, H. H.: Ergotoxine and some other constituents of ergot. Biochem. J. 2, 240.PubMedGoogle Scholar
  10. 1909. — —Über Mutterkorn. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 61, 113.Google Scholar
  11. — — The water soluble active principles of ergot. J. Physiol. (Lond.) 38, 77P.Google Scholar
  12. Dale, H. H., Laidlaw, P. P., Symons, C. T.: Acceleration of the mammalian heart-beat by stimulation of the vagus nerve. J. Physiol. (Lond.) 39, 13P.Google Scholar
  13. — — The action of an active principle from Apocynum. Heart 1, 138.Google Scholar
  14. — — The action of some diuretics. Proc. roy. Soc. Med., therap. Sect. 3, 38.Google Scholar
  15. — — The physiological action of primary fatty amines. J. Physiol. (Lond.) 38, 22P.Google Scholar
  16. Dale, H. H.: Note on nutmeg poisoning. Proc. roy. Soc. Med., therap. Sect. 2, 69.Google Scholar
  17. Dixon, W. E.: The action of pressor amines produced by putrefaction. J. Physiol. (Lond.) 39, 25.Google Scholar
  18. — The action of extracts of the pituitary body. Biochem. J. 4, 427.Google Scholar
  19. 1910. Barger, G., Dale, H. H.: A third active principle in ergot extracts. (Prel. note) Proc. chem. Soc. (Lond.) 26, 218.Google Scholar
  20. — — The presence in ergot and physiological activity of β-imidazolylethylamine. (Prel. Com.) J. Physiol. (Lond.) 40, 38P.Google Scholar
  21. Dale, H. H., Laidlaw, P. P., Symons, C. T.: A reversed action of the vagus on the mammalian heart. J. Physiol. (Lond.) 41, 1.Google Scholar
  22. — — The physiological aticon of β-iminazolylethylamine. J. Physiol. (Lond.) 41, 318Google Scholar
  23. Barger, G., Dale, H. H.: Die physiologische Wirkung einer Secalebase und deren Identifizierung als Imidazolyläthylamin. Zbl. Physiol. 24, 885.Google Scholar
  24. — — 4-β-aminoethylglyoxaline (β-iminazolylethylamine) and the other active principles of ergot. J. chem. Soc. Trans. 97, II, 2592.Google Scholar
  25. Dale, H. H.: The active principles of ergot. Brit. med. J. II, 1610.Google Scholar
  26. — The active principles of ergot. Proc. Internat. Physiol. Congr., Vienna, Sept., 27–30.Google Scholar
  27. 1911. Barger, G., Dale, H. H.: Chemical structure and sympathomimetic action of amines. J. Physiol. (Lond.) 41, 19.Google Scholar
  28. Dale, H. H., Laidlaw, P. P.: Further observations on the action of β-iminazolylethylamine. J. Physiol. (Lond.) 43, 182.Google Scholar
  29. — — Note on a reversed action of the chorda tympani on salivary secretion. J. Physiol. (Lond.) 43, 196.Google Scholar
  30. Barger, G., Dale, H. H.: β-iminazolylethylamine a depressor constituent of intestinal mucosa. J. Physiol. (Lond.) 41, 499.Google Scholar
  31. 1912. Dale, H. H., Laidlaw, P. P.: A method of standardising pituitary (infundibular) extracts. J. Pharmacol. 4, 75.Google Scholar
  32. — — A simple coagulometer. J. Path. Bac. 16, 351.Google Scholar
  33. — — The physiological action of cytisine, the active alkaloid of laburnum (Cytisus laburnum). J. Pharmacol. 3, 205.Google Scholar
  34. — — A method of preparing secretin. J. Physiol. (Lond.) 44, 11P.Google Scholar
  35. — — Some actions of pilocarpine and nicotine. (Prel. Com.) J. Physiol. (Lond.) 44, 12P.Google Scholar
  36. — — The significance of the suprarenal capsules in the action of certain alkaloids. J. Physiol. (Lond.) 45, 1.PubMedGoogle Scholar
  37. — The anaphylactic reaction of plain muscle in the guinea-pig. (Prel. Com.) J. Physiol. 45, 27P. Same title. J. Pharmacol. 4, 167.Google Scholar
  38. — Ergot and its active principles. J. Amer. pharm. Ass., Nov.Google Scholar
  39. 1913. Carr, F. H., Dale, H. H.: Ergot and its preparations; a critical review of the requirements of the British Pharmacopoeia. Pharm. J. 4. s., 37, 130.Google Scholar
  40. — — Ergot, and its preparations. Med. Pr, N.S. 96, 254.Google Scholar
  41. Dale, H. H.: On the action of ergotoxine; with special reference to the existence of sympathetic vasodilators. J. Physiol. (Lond.) 46, 291.Google Scholar
  42. — The effect of small variations in concentration of Ringer’s solution on the response of isolated plain muscle. (Prel. Com.) J. Physiol. (Lond.) 46, 19P.Google Scholar
  43. — The effect of varying tonicity on the anaphylactic and other reactions of plain muscle. J. Pharmacol. 4, 517.Google Scholar
  44. 1914. — Ewins, A. J.: Choline-esters and muscarine. (Prel. Com.) J. Physiol. (Lond.) 48, 24P.Google Scholar
  45. Barger, G., Dale, H. H.: Liver nitrogen in anaphylaxis. Biochem. J. 8, 670.Google Scholar
  46. Dale, H. H.: The occurrence in ergot and action of acetylcholine. (Prel. Com.) J. Physiol. (Lond.) 48, 3P.Google Scholar
  47. — The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharmacol. 6, 147.Google Scholar
  48. 1915. Barger, G., Dale, H. H.: Note on a supposed soluble toxin, produced in artificial culture by the bacillus of malignant oedema. Brit. med. J. II, 808.Google Scholar
  49. Dale, H. H.: A preliminary note on chronic poisoning by emetine. Brit. med. J. II, 895.Google Scholar
  50. Burn, J. H., Dale, H. H.: The action of certain quarternary ammonium bases. J. Pharmacol. 6, 417.Google Scholar
  51. Dale, H. H.: The physiology of the thyroid gland. Practitioner 94, 16.Google Scholar
  52. 1916. — Walpole, G. S.: Some experiments on factors concerned in the formation of thrombin. Biochem. J. 10, 331.PubMedGoogle Scholar
  53. Hartley, P.: Anaphylaxis to the separated proteins of horse-serum. Biochem. J. 10, 408.PubMedGoogle Scholar
  54. — Treatment of carriers of amoebic dysentery. Note on the use of the double iodide of emetine and bismuth. Lancet II, 183.Google Scholar
  55. 1917. — Dobell, C.: Experiments on the therapeutics of amoebic dysentery. J. Pharmacol. 10, 399.Google Scholar
  56. Barger, G., Dale, H. H., Durham, F. M.: “Collosol” cocaine. Lancet II, 825.Google Scholar
  57. Dale, H. H.: The treatment of amoebic dysentery. (Letter) Lancet I, 780.Google Scholar
  58. 1918. — Richards, A. N.: The vasodilator action of histamine and of some other substances. J. Physiol. (Lond.) 52, 110.PubMedGoogle Scholar
  59. 1919. —Contribution to general discussion on shock (introduction by W. M. Bayliss). Proc. roy. Soc. Med. 12, 4.PubMedGoogle Scholar
  60. Laidlaw, P. P.: A simple method of short-circuiting the portal circulation. J. Physiol. (Lond.) 52, 351.PubMedGoogle Scholar
  61. — — Histamine shock. J. Physiol. (Lond.) 52, 355.PubMedGoogle Scholar
  62. — Royal Society Croonian Lecture. The biological significance of anaphylaxis. (Abstract) Proc. roy. Soc. B 90, 556.Google Scholar
  63. Laidlaw, P. P., Richards, A. N.: The action of histamine: its bearing on traumatic toxaemia as a factor in shock. In: Med. Res. Com. Special Report, Ser. No. 26, 8.Google Scholar
  64. Dakin, H. D., Dale, H. H.: Chemical structure and antigenic specificity. A comparison of the crystalline egg-albumins of the hen and the duck. Biochem. J. 13, 248.Google Scholar
  65. Richards, A. N., Dale, H. H.: Experiments on the action of histamine. Proc. path. Soc. Philad., N.S. 22, 32.Google Scholar
  66. Dale, H. H.: Supplementary note on histamine shock. Med. Res. Com. Spec. Rep. Ser. No. 26, 15.Google Scholar
  67. 1920. —Royal Society Croonian Lecture. The biological significance of anaphylaxis. Proc. roy. Soc. B 91, 126.Google Scholar
  68. Evans, C. L.: Colorimetric determination of the reaction of blood by dialysis. J. Physiol. (Lond.) 54, 167.PubMedGoogle Scholar
  69. — The use of colloidal preparations in medicine. J. Soc. chem. Ind. (Lond.) 39, 211.Google Scholar
  70. — Conditions which are conducive to the production of shock by histamine. Brit. J. exp. Path. 1, 103.Google Scholar
  71. — The Herter Lectures. Baltimore 1919. 1. Capillary poisons and shock. Johns Hopk. Hosp. Bull. 31, 257. 2. Anaphylaxis. Johns Hopk. Hosp. Bull. 31, 310. 3. Chemical structure and physiological action. Johns Hopk. Hosp. Bull. 31, 373.Google Scholar
  72. — Contribution to: Discussion on the value of alcohol as a therapeutic agent. Proc. roy. Soc. Med., therap. Sect. 13, 31.Google Scholar
  73. 1921. —Recent tendencies in chemotherapy. President’s Address. Proc. roy. Soc. Med., therap. Sect. 14, 7.Google Scholar
  74. Dudley, H. W.: The physiological action of N-methylhistamine and of tetrahydropyrido-3.4-iminazole (“imidazolisopiperidin” of Fränkel). J. Pharmacol. 18, 103.Google Scholar
  75. — — On the pituitary active principles and histamine. J. Pharmacol. 18, 27.Google Scholar
  76. 1921. — Kellaway, C. H.: Anaphylaxis and immunity in vitro. (Prel. Com.) J. Physiol. (Lond.) 54, 142P.Google Scholar
  77. — Anaphylaxis. St. Bart. Hosp. J. 28, 163.Google Scholar
  78. — Note on the reversal of vagus action by quinidine, as seen in the heart of the cat. Heart 9, 87.Google Scholar
  79. — The nature and cause of wound shock. Harvey Society Lectures, New York, p. 27.Google Scholar
  80. — The use of alcohol in medicine. Brit. J. Inebr. 19, 27.Google Scholar
  81. Hill, L.: Anaesthesia with nitrous oxide and oxygen under pressure. Lancet II, 326.Google Scholar
  82. — The work of the National Institute for Medical Research. Lancet II, 112 (and The Fight Against Disease (Res. Def. Soc.) October 1921).Google Scholar
  83. — Anaphylatoxin. (Abstract) Brit. med. J. II, 689.Google Scholar
  84. 1922. —Francis Arthur Bainbridge, 1874–1921. (Obit. Not.) Proc. roy. Soc. B 93, 24.Google Scholar
  85. White, C. F., et al.: Report on an experimental and clinical comparison of the therapeutic properties of different preparations of 914 (neosalvarsan). Lancet I, 779. (Based on experiments made in conjunction with J. H. Burn, Florence M. Durham, Juliette Marchal and C. H. Mills.)Google Scholar
  86. Evans, C. L.: Effects on the circulation of changes in the carbondioxide content of the blood. J. Physiol. (Lond.) 56, 125.PubMedGoogle Scholar
  87. Spiro, K.: Die wirksamen Alkaloide des Mutterkorns. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 95, 337.Google Scholar
  88. Kellaway, C. H.: Anaphylaxis and anaphylatoxins. Phil. Trans. B. 211, 273.Google Scholar
  89. Burn, J. H., Dale, H. H.: Reports on biological standards. 1. Pituitary extracts. Spec. Rep. Ser. med. Res. Coun. No 69. (Lond.)Google Scholar
  90. Dale, H. H.: British Medical Association Lecture. Specific sensitiveness and anaphylaxis. Brit. med. J. I, 45.Google Scholar
  91. 1923. —The value of ergot in obstetrical and gynaecological practice; with special reference to its present position in the British Pharmacopoeia. Proc. roy. Soc. Med., therap. Sect. 16, 1.Google Scholar
  92. — Colloidal preparations. (Letter) Brit. med. J. I, 786.Google Scholar
  93. Hadfield, C. F., King, H.: The anaesthetic action of pure ether. Lancet I, 424.Google Scholar
  94. — The Oliver-Sharpey Lectures to the Royal College of Physicians. The activity of the capillary blood vessels, and its relation to certain forms of toxaemia. Brit. med. J. I, 959 and 1006.Google Scholar
  95. — Chemotherapy. Physiol. Rev. 3, 359.Google Scholar
  96. — The physiology of insulin. Lancet I, 989.Google Scholar
  97. 1924. —The search for specific remedies. Proc. roy. Instn. G. B. 23, 635.Google Scholar
  98. Burn, J. H., Dale, H. H.: On the location and nature of the action of insulin. J. Physiol. (Lond.) 59, 164.PubMedGoogle Scholar
  99. Dale, H. H.: Memo. on the present position with regard to the testing of salvarsan etc. League of Nations. June, 1925.Google Scholar
  100. — Presidential Address to Section of Physiology, Brit. Assoc., Toronto, 1924. Progress and prospects in chemotherapy. Brit. med. J. II, 219–223.Google Scholar
  101. 1925. —The circulation of blood in the capillary vessels. Proc. roy. Instn. B. B. 24, 623.Google Scholar
  102. 1926. — Drummond, J. C., Henderson, L. J., Hill, A. V.: Lectures on certain aspects of biochemistry, p. 313. London: Univ. London. Press.Google Scholar
  103. Burn, J. H., Dale, H. H.: The vaso-dilator action of histamine and its physiological significance. J. Physiol. (Lond.) 61, 185.PubMedGoogle Scholar
  104. Dale, H. H., Gasser, H. S.: The pharmacology of denervated mammalian muscle. I. The nature of the substances producing contracture. J. Pharmacol. 29, 53.Google Scholar
  105. Gasser, H. S., Dale, H. H.: The pharmacology of denervated mammalian muscle. II. Some phenomena of antagonism and the formation of lactic acid in chemical contracture. J. Pharmacol. 28, 287.Google Scholar
  106. Best, G. H., Dale, H. H., Hoet, J. P., Marks, H. P.: Oxidation and storage of glucose under the action of insulin. Proc. roy. Soc. B 100, 55.Google Scholar
  107. Dale, H. H.: Introduction. The biological standardisation of insulin, p. 398. Geneva: League of Nations Health Organisation.Google Scholar
  108. — Arthur Robertson Cushny. (Obit. Not.) Arch. int. Pharmacodyn. 32, 1.Google Scholar
  109. — Arthur Robertson Cushny. (Obit. Not.) Proc. roy. Soc. B 100, 19.Google Scholar
  110. — The scientific and industrial problems presented by the hormones—the natural drugs of the body. The experimental study and use of hormones. J. Soc. chem. Ind. (Lond.) 45, 235.Google Scholar
  111. 1927. — Dudley, H. W.: An active constituent of the preparation called Glukhorment. Brit. med. J. II, 1027.Google Scholar
  112. Richards, A. N.: The depressor (vaso-dilator) action of adrenaline. J. Physiol. (Lond.) 63, 201.PubMedGoogle Scholar
  113. Best, G. H., Dale, H. H., Dudley, H. W., Thorpe, W. V.: The nature of the vasodilator constituents of certain tissue extracts. J. Physiol. (Lond.) 62, 397.PubMedGoogle Scholar
  114. Dale, H. H.: Die Theorie der Insulinwirkung. Karlsbader ärztliche Vorträge 9, 393.Google Scholar
  115. 1928. — Schuster, E. H. J.: A double perfusion pump. J. Physiol. (Lond.) 64, 356.PubMedGoogle Scholar
  116. — Discussion on the action of synthalin. Proc. roy. Soc. Med., therap. Sect. 21, 527.Google Scholar
  117. — Some reactions of pharmacology on pharmacy. Pharm. J. 120, 245.Google Scholar
  118. 1929. —Croonian Lectures to the Royal College of Physicians: Some chemical factors in the control of the circulation. 1. Introduction, vaso-motor hormones. Lancet I, 1179. 2. Local vasodilator reactions—histamine. Lancet I, 1233. 3. Local vasodilator reactions. Histamine cont., acetylcholine, conclusion. Lancet I, 1285.Google Scholar
  119. Dudley, H. W.: The presence of histamine and acetylcholine in the spleen of the ox and the horse. J. Physiol. (Lond.) 68, 97.PubMedGoogle Scholar
  120. 1930. Corkill, A. B., Dale, H. H., Marks, H. P.: The respiratory quotient of the eviscerated spinal cat. J. Physiol. (Lond.) 70, 86.PubMedGoogle Scholar
  121. Dale, H. H., Gaddum, J. H.: Reactions of denervated voluntary muscle, and their bearing on the mode of action of parasympathetic and related nerves. J. Physiol. (Lond.) 70, 109.PubMedGoogle Scholar
  122. — In Memoriam Rudolf Magnus 1873–1927. Introductory note to Lane Lectures on Experimental Pharmacology and Medicine, by Rudolf Magnus. Stanford: University Press.Google Scholar
  123. 1931. — Dudley, H. W.: Enthält das normale Blut Acetylcholin? Mit Berücksichtigung der Arbeit von Kapfhammer und Bischoff. Hoppe-Seylers. Z. physiol. Chem. 198, 85.Google Scholar
  124. — The effect of research on curative medicine. Stephen Paget Memorial Lecture. Brit. med. J. I, 1076.Google Scholar
  125. — Presidential Address to Section of Physiology, Brit. Assoc. (Centen. Meeting), London. (Introducing discussion on biological nature of viruses.) Ann. Rep. Brit. Assn., p. 172.Google Scholar
  126. — British Science Guild. The Norman Lockyer Lecture 1931. Biology and civilization. Nature (Lond.) 128, 897 (1931).Google Scholar
  127. 1932. —Über Kreislaufwirkungen körpereigener Stoffe. (Deut. Kongr. inn. Med., Wiesbaden, 1932). Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 167, 21.Google Scholar
  128. Bauer, W., Dale, H. H., Poulsson, L. T., Richards, D. W.: The control of circulation through the liver. J. Physiol. (Lond.) 74, 343.PubMedGoogle Scholar
  129. Dale, H. H., Marble, A., Marks, H. P.: The effects on dogs of large doses of calciferol (Vitamin D). Proc. roy. Soc. B 111, 522.Google Scholar
  130. — Notes on communication by J. Chassar Moir on: The action of ergot preparations on the puerperal uterus. Brit. med. J. I, 1119.Google Scholar
  131. — Presidential Address (Section of Physiology, Brit. Med. Ass., Centenary Meeting). The relation of physiology to medicine in research and education. Brit. med. J. II, 1043.Google Scholar
  132. — Some therapeutic problems of the future. (Harrison Memorial Lecture to the Pharmaceutical Society) Pharm. J. 129, 515.Google Scholar
  133. 1933. —Virus diseases (Substance of a lecture entitled: Ultramicroscopic organisms and the troubles which they cause, delivered at Bedford College, London, on 1 March 1933). Nature (Lond.) 131, 370.Google Scholar
  134. 1933. —The Dohme Lectures (3). Baltimore, 1933. Progress in autopharmacology. A survey of present knowledge of the chemical regulation of certain functions by natural constituents of the tissues. Johns Hopk. Hosp. Bull. 53, 297.Google Scholar
  135. — Academic and industrial research in the field of therapeutics. An address delivered at the opening ceremony of Merck Research Laboratory, Rahway, N.J., 25 April. Science 77, 521.PubMedGoogle Scholar
  136. 1934. — Feldberg, W.: The chemical transmitter of effects of the gastric vagus. J. Physiol. (Lond.) 80, 16P.Google Scholar
  137. — Nomenclature of fibres in the autonomic system and their effects. J. Physiol. (Lond.) 80, 10P.Google Scholar
  138. — The Linacre Lecture, Cambridge, 1934. Chemical transmission of the effects of nerve impulses. Brit. med. J. I, 835.Google Scholar
  139. Feldberg, W.: The chemical transmitter of vagus effects to the stomach. J. Physiol. (Lond.) 81, 320.PubMedGoogle Scholar
  140. — — The chemical transmitter of nervous stimuli to the sweat glands of the cat. J. Physiol. (Lond.) 81, 40P.Google Scholar
  141. — — Chemical transmission at motor nerve endings in voluntary muscle. J. Physiol. (Lond.) 81, 39P.Google Scholar
  142. — — The chemical of secretory impulses to the sweat glands of the cat. J. Physiol. (Lond.) 82, 121.PubMedGoogle Scholar
  143. — Chemical ideas in medicine and biology. Science 80, 343. Address given at the opening ceremony of the Eli Lilly Research Laboratories, 11 October 1934.PubMedGoogle Scholar
  144. 1935. —Walter Ernest Dixon Memorial Lecture, 1934. Pharmacology and nerveendings. Proc. roy. Soc. Med., therap. Sect. 1935, 28, 319.Google Scholar
  145. — Note (on nomenclature) appended to Feldberg, W., and Guimarais, J. A. J. Physiol. (Lond.) 83, 43P.Google Scholar
  146. — Contribution to discussion on traumatic shock. Proc. roy. Soc. Med., surg. Sect. 28, 1493.Google Scholar
  147. — Viruses and heterogenesis. An old problem in a new form. Huxley Memorial Lecture, 2 May 1935. London: Macmillan & Co.Google Scholar
  148. — Discussion. The new ergot alkaloid. Science 82, 99.PubMedGoogle Scholar
  149. Brown, G. L., Dale, H. H.: The pharmacology of ergometrine. Proc. roy. Soc. B 118, 446.Google Scholar
  150. Dale, H. H.: Harold Ward Dudley. 1887–1935. Obit. Not. Roy. Soc. 1935, 1, 595.Google Scholar
  151. — Die Pharmakologie des Mutterkorns. Schweiz. med. Wschr. 65, 885. With Discussion by Profs. A. Stoll, E. Rothlin, W. Loeffler and Sir Henry Dale. Schweiz. med. Wschr. 65, 1077.Google Scholar
  152. — The Harveian Oration before the Royal College of Physicians. Some epochs in medical research. London: H. K. Lewis & Co. 1935. Also Brit. med. J. 1935, II, 771.Google Scholar
  153. 1936. —Recent developments in the pharmacology of ergot, especially of ergometrine. Lecture Ned. Vereeniging voor Physiologie en Pharmacologie 5. III. 1936. Acta brev. neerl. Physiol. 6, 1.Google Scholar
  154. Brown, G. L., Dale, H. H.: Perfusion with solution of haemolysed red corpuscles. J. Physiol. (Lond.) 86, 42P.Google Scholar
  155. Dale, H. H., Feldberg, W., Vogt, M.: Release of acetylcholine at voluntary motor nerve endings. J. Physiol. (Lond.) 86, 353.Google Scholar
  156. Brown, G. L., Dale, H. H., Feldberg, W.: Chemical transmission of excitation from motor nerve to voluntary muscle. J. Physiol. (Lond.) 87, 42P.Google Scholar
  157. — — — Reactions of the normal mammalian muscle to acetylcholine and to eserine. J. Physiol. (Lond.) 87, 394.PubMedGoogle Scholar
  158. Dale, H. H.: Some recent extensions of chemical transmission. Cold Spr. Harb. Symp. quant. Biol. 4, 143.Google Scholar
  159. Gaddum, J. H. (Eingeleitet von Dale, H. H.): Gefäßerweiternde Stoffe der Gewebe. Leipzig: Georg Thieme.Google Scholar
  160. 1937. Dale, H. H.: Transmission of nervous effects by acetylcholine. Harvey Lectures, New York, 1936–1937. Lecture delivered 20 May 1937. Harvey Lect. 1937, 32, 229.Google Scholar
  161. — International standard progesterone. Bull. Hth Org. L. o.N. 6, 892.Google Scholar
  162. — Some recent extensions of the chemical transmission of the effects of nerve impulses. Nobel Lecture, December 1936. Les Prix Nobel en 1936 (Stockholm, 1937).Google Scholar
  163. Medicine as an experimental science. Address at the celebration of the 150th Anniversary of the Founding of the College of Physicians of Philadelphia, 14 May 1937. Trans. Coll. Phycns Philad. 1937, 4, (Suppl.) 4th. Ser. p. 52.Google Scholar
  164. — Du Bois-Reymond and chemical transmission. J. Physiol. (Lond.) 91, 4P.Google Scholar
  165. 1938. —The William Henry Welch Lectures, 1937: Acetylcholine as a chemical transmitter of the effects of nerve impulses. 1. History of ideas and evidence. Peripheral autonomic actions. Functional nomenclature of nerve fibres. 2. Chemical transmission at ganglionic synapses and voluntary motor nerve endings. Some general considerations. J. Mt Sinai Hosp. 1938, 4, 401.Google Scholar
  166. — Acetylcholine as transmitter of the effects of nerve impulses. I. Pavlov Number, Physiol. J., U.S.S.R. 24, 116.Google Scholar
  167. — Natural chemical stimulators. Edinb. med. J., N.S. (IVth) 45, 461. (The Sharpey Schafer Memorial Lecture delivered to the Faculty of Medicine, University of Edinburgh, 1937).Google Scholar
  168. — Chemical agents transmitting nervous excitations. Irish J. med. Sci., June 1938, 1 (John Mallet Purser Lecture, 1938).Google Scholar
  169. — The future of medicine. Report of an address given at the opening of the new session, Guy’s Hospital, on 14 October 1938. Guy’s Hosp. Gaz. 52, 396.Google Scholar
  170. — Discussion on the scope and future of teaching and research in pharmacology. Introduction to a Discussion Meeting of Pharmacologists. Proc. XVIth International Physiological Congress, Zurich.Google Scholar
  171. 1939. —John Jacob Abel. 1857–1938. Obit. Not. Roy. Soc. 1939, 2, 577.Google Scholar
  172. — Biological standardisation. (Address given to the Annual General Meeting of the Society of Public Analysts, 1939) Analyst 64, 554.Google Scholar
  173. — Chemical mediation in the peripheral nervous system and its relation to endocrine organs. Comptes Rendus. IIIe Congrès Neurologique International, Copenhagen, 1939, p. 37. Also (in French) Rev. neurol. 1940, 72, 347.Google Scholar
  174. — Physiology of the nervous system. Science 90, 393. Discussion.PubMedGoogle Scholar
  175. — Address to the Assembly of the Faculties of University College, London, 6 July 1939. Annual Report, University of London, University College, 1939–1940, p. 46.Google Scholar
  176. 1940. —George Barger. Obit. Not. Roy. Soc., 1940, 4, 63. Lancet 1939, I 116. Also Nature (Lond.) 1939, 143, 107.Google Scholar
  177. — Sir Frederick Andrewes. Dictionary of National Biography. Suppl. 1931–1940, p. 14.Google Scholar
  178. 1941. —Sir Frederick Banting. Obit. Not. Brit. med. J. I, 383.Google Scholar
  179. — Patrick Playfair Laidlaw. Obit. Not. Roy. Soc. 1941, 3, 427.Google Scholar
  180. — A new era in medicinal treatment. Mem. Proc. Manchr. Lit. Phil. Soc. 1941, 84, 42.Google Scholar
  181. — Address of the President, Anniversary Meeting, 1941. Proc. roy. Soc. B 130, 227.Google Scholar
  182. 1942. —The mode of action of chemotherapeutic agents. A discussion held by the Biochemical Society, 29 November 1941. Biochem. J. 36, 3.Google Scholar
  183. — Wartime arrangements for international biological standards and the new standard for pituitary (posterior lobe) preparations. Brit. med. J. II, 385.Google Scholar
  184. — Edgar Vincent, Viscount D’Abernon, 1857–1941. Obit. Not. Roy. Soc. 4, 83.Google Scholar
  185. 1943. —A prospect in therapeutics. (Frederick Price Lecture to the Royal College of Physicians, Edinburgh, 2 July 1943) Brit. med. J. II, 411. Google Scholar
  186. — Address of the President, Anniversary Meeting, 1942. Introduction to Addresses at Isaac Newton Tercentenary. Proc. roy. Soc. A 181, 211 and 224.Google Scholar
  187. 1944. —Address of the President, 1943. Proc. roy. Soc. A 1944, 182, 217; Proc. roy. Soc. B 132, 1.Google Scholar
  188. — Henry George Lyons, 1864–1944. Obit. Not. Roy. Soc. 1944, 4, 795.Google Scholar
  189. 1944. —International activities in science. Nature (Lond.) 154, 725.Google Scholar
  190. — The natural history and chemistry of drugs. Address to The Pharmaceutical Society of Great Britain, 13 January 1944. Pharm. J. 152, 34.Google Scholar
  191. — Discussion (with J. B. Buxton and G. W. Pickering) on principles and relationships involved in medical and veterinary education. Proc. roy. Soc. Med. 38, 119.Google Scholar
  192. 1945. —Address of the President, 1944. Proc. Roy. Soc. B 1945, 132, 333.Google Scholar
  193. — A hitherto unpublished letter of Isaac Newton. Nature (Lond.) 156, 193.Google Scholar
  194. — The mission of science. Nature (Lond.) 156, 677.PubMedGoogle Scholar
  195. 1946. —Address of the President, 1945. Proc. roy. Soc. B 1946, 133, 123.Google Scholar
  196. Experiment in medicine. History of Science Lecture, Cambridge, 2, March 1946. Camb. Hist. J. 8, 166.Google Scholar
  197. — Electric fishes. (Abstract) Discourse at Royal Institution. Proc. Roy. Instn. G.B. 33, 662.Google Scholar
  198. — Diabetic Association Silver Jubilee Celebration of the Discovery of Insulin. Memorial Address. Diabetic J. 4, 392.Google Scholar
  199. 1947. —Science in war and peace. The Presidential Address to the British Association Meeting, Dundee, 27 August 1947. The Advanc. Sci. 4, 151. Also Nature (Lond.) 160, 283.Google Scholar
  200. — Science and medicine. (Broadcast) Chapter in Atomic Challenge, B.B.C. Symposium p. 107. London: Winchester Publications.Google Scholar
  201. The Pilgrim Trust Lecture, 1946. The freedom of science. Proc. Amer. Phil. Soc. 1947, 91, 64.Google Scholar
  202. Walter Bradford Cannon. Obit. Not. Roy. Soc., 1947, 5, 407.Google Scholar
  203. — The part of chemistry in the new therapeutics (XI International Congress of Pure and Applied Chemistry, 1947, London, 17 to 24 July) Suppl. to Chemistry and Industry, 1948.Google Scholar
  204. 1948. — Chemistry and medicinal treatment. Third Dalton Lecture, 1947. Royal Institute of Chemistry, 1948.Google Scholar
  205. — Transmission of effets from the endings of nerve fibres. Nature (Lond.) 162, 558.Google Scholar
  206. — Antihistamine substances. (Opening to a discussion in the Section of Pharmacology, B.M. Ass., 1948) Brit. med. J. II, 281.Google Scholar
  207. — Accident and opportunism in medical research. (Popular Lecture at the Annual Meeting, B.M. Ass., 1948) Brit. med. J. II, 451.Google Scholar
  208. — The physiological basis of neuromuscular disorders. (Opening a discussion in the Section of Physiology, B.M. Ass., 1948) Brit. med. J. II, 889.Google Scholar
  209. Frederick Gowland Hopkins. Obit. Not Roy. Soc. 1948, 6, 115.Google Scholar
  210. Medicinal treatment—then and now. B.B.C. Broadcast, 4 September 1946. Science Survey, 1948, p. 239. London: Sampson Low, Marston & Co. Ltd.Google Scholar
  211. — Atomic energy. Its international implications. Introductory Chapter The Objective, p. 15. Royal Institute of International Affairs, London. Oxford: University Press.Google Scholar
  212. Research and organisation. (Conference at Manchester on the place of Universities in the Community, 10 May 1947). The Advanc. Sci. 1948, 5, 11.Google Scholar
  213. 1949. —Contribution to Discussion. Annual Conference of Atomic Scientists’ Association held at Beaver Hall, London, on 30 October 1948. Atomic Scientists’ News, 1949, 2, No 4, 91.Google Scholar
  214. — Thomas Addison: Pioneer of endocrinology. (The Addison Lecture given at Guy’s Hospital on 23 June 1949) Brit. med. J. II, 347.Google Scholar
  215. — Medical research as an aim in life. (Address to the Roy. Med. Soc., Edinb.,) Edinb. med. J. 56, 273.PubMedGoogle Scholar
  216. — Barcroft Memorial Conference. Haemoglobin. (Tribute to Sir Joseph Barcroft), p. 4. London: Butterworths Scientific Publications.Google Scholar
  217. — The atomic problem now. Spectator, 30 September 1949, p. 409.Google Scholar
  218. — Letter of resignation of Honorary Membership of the Soviet Academy of Sciences of the U.S.S.R. Discovery 10, 32.Google Scholar
  219. 1950. —The science of genetics. Caribbean med. J. 1950. 12, 96.Google Scholar
  220. — Advances in medicinal therapeutics. Brit. Med. J. I, 1.Google Scholar
  221. — Some personal memories of Lord Rutherford of Nelson. Lecture delivered at Cawthron Institute, Nelson, New Zealand. Nelson: Published by R. W. Stiles and Co. Ltd.Google Scholar
  222. — The action and uses of the antihistamine drugs as applied to dermatology. (Introduction to a discussion held at the Annual Meeting of the Brit. Ass. Derm., 1949) Brit. J. Derm. 62, 151.Google Scholar
  223. — The discovery of insulin, and its introduction into therapeutics. Rapport présenté au II Congrès International de Thérapeutique, June 1949. Editions Arscia, Bruxelles, 1950.Google Scholar
  224. — The pharmacology of histamine: with a brief survey of evidence for its occurrence, liberation, and participation in natural reactions. (Introduction to a Symposium on Antihistamines, October, 1947) Ann. N.Y. Acad. Sci. 50, 1017.PubMedGoogle Scholar
  225. — Scientific method in medical research. (Opening to a course of lectures: The scientific basis of medicine, arranged by the British Postgraduate Medical Federation) Brit. med. J. II, 1185.Google Scholar
  226. — Science and broadcasting. B.B.C. Quarterly 5, 136.Google Scholar
  227. — Professor E. D. Adrian, O. M., F. R. S. Electroenceph. clin. Neurophysiol. (Special Number), 2, 373.Google Scholar
  228. — The chemical transmission of nerve impulses. In: Nervous system. Chambers Encyclopaedia, p. 776. London: George Newnes Ltd. vol. 9Google Scholar
  229. — Sir Frederick Gowland Hopkins. Dict. of Nat. Biography. Suppl. 1941–1950, p. 406.Google Scholar
  230. — Sir Henry Lyons. Dict. of Nat. Biography. Suppl. 1941–1950, p. 543.Google Scholar
  231. — Rutherford and the Atom. Spectator, 1 December 1950, p. 607.Google Scholar
  232. 1951. —Medicine, yesterday and tomorrow. Brit. med. J. II, 1.Google Scholar
  233. — The eye as a physiological reagent. (Bowman Lecture, Ophthal. Soc., 29 March 1951) Trans. ophthal. Soc. U.K. 71, 117.Google Scholar
  234. Introduction to Paul Ehrlich, by Marthe Marquardt, 1949, p. 13. London: William Heinemann Medical Books Ltd. Google Scholar
  235. , New York: Henry Schuman, 1951. (In German).Google Scholar
  236. Introduction to Paul Ehrlich, by Marthe Marquardt, Berlin-Göttingen-Heidelberg: Springer 1951.Google Scholar
  237. — Measurement in medicine. Introduction by Sir Henry Dale. Brit. med. Bull. 7, 261.PubMedGoogle Scholar
  238. — Harvey and the circulation of the blood. The history of science, p. 55. London: Broadcast Talks, Cohen & West Ltd.Google Scholar
  239. — Transmission of excitation from nerve endings. The evidence for a chemical agency. Times Review of the Progress of Science (Quarterly), No. 2, p. 3.Google Scholar
  240. — The changing face of medicine. Practitioner 167, 309.PubMedGoogle Scholar
  241. — What Nagasaki means. Spectator, 13 July, 1951, p. 54.Google Scholar
  242. 1952. —Mécanisme de l’anaphylaxie. (Fiftieth Anniversary of the Discovery of Anaphylaxis). Presse méd. 60, 680. Also (in English) Acta allerg. 5, 191.PubMedGoogle Scholar
  243. — Sir Richard Gregory. (Obituary) Nature (Lond.) 170, 521.Google Scholar
  244. — Transmission of effects from nerve endings. A survey of the significance of present knowledge. (Lecture at University of St. Andrews Medical School. 13 March 1952). Oxford: Univ. Press.Google Scholar
  245. 1953. — The place of research in medical education and practice. (Inaugural Address. Royal Free Hospital School of Medicine. 3 October 1952.) Roy. Free Hosp. Mag. No 16.Google Scholar
  246. — In: What I believe, by Sir James Marchant, p. 67–82. London: Odhams Press Ltd.Google Scholar
  247. — Reizübertragungen durch chemische Mittel im ganzen Nervensystem. Wien. klin. Wschr. 65, 455.PubMedGoogle Scholar
  248. — Adventures in physiology, with excursions into autopharmacology. London: Pergamon Press.Google Scholar
  249. — A chemical phase in the transmission of nervous effects. Endeavour 12, No 47, 117.Google Scholar
  250. Charles Halliley Kellaway, 1889–1952. Obit. Not. Fellows Roy. Soc. 8, 503.Google Scholar
  251. — The Library of the Royal Society of Medicine. Brit. med. J. II, 1264.Google Scholar
  252. 1954. —Paul Ehrlich—Born March 14, 1854. Brit. med. J. I, 659.Google Scholar
  253. 1954. —Histamine and its antagonists. J. Lar. Otol. Lond. 68, 28.Google Scholar
  254. — The Royal Society of Medicine Wellcome Research Library. Proc. roy. Soc. Med. 47, 1.Google Scholar
  255. — Changes and prospects in Medicinal treatment. The Harben Lectures 1953. J. R. Inst. Pub. Hlth Hyg. 17, 39, 70, 98.Google Scholar
  256. — The beginnings and the prospects of neurohumoral transmission. Pharmacol. Rev. 6, 7.PubMedGoogle Scholar
  257. — Dedication of the Charles H. Best Institute. Diabetes 3, 30.Google Scholar
  258. Paul Ehrlich. Clin. nuova (Roma) 18, 403.Google Scholar
  259. Paul Ehrlich and modern therapeutics. Ned. T. Geneesk. 98, 3028.PubMedGoogle Scholar
  260. — An autumn gleaning. London: Pergamon Press.Google Scholar
  261. — Memorable experiences in research. Diabetes 3, 20.Google Scholar
  262. — The changing outlook in medicine. Diabetes 3, 415.PubMedGoogle Scholar
  263. — Hormones of the pituitary posterior lobe. Banting Memorial Lecture. Diabetes 3, 435.PubMedGoogle Scholar
  264. 1955. —Junctional transmission of nervous effects by chemical agents. Mayo Foundation Lecture. Proc. Mayo Clin. 30, 5.Google Scholar
  265. Edward Mellanby, 1884–1995. Biog. Mems Fellows Roy. Soc. 1, 193.Google Scholar
  266. — A historical survey of knowledge of histamine and its functions. Int. Ass. Allergology Congr. Rio de Janeior, Brazil.Google Scholar
  267. — Humanity’s rising debt to medical research. Paget Memorial Lecture. Conquest 44, 2.Google Scholar
  268. 1956. —Medical aims and ideals. The Huxley Lecture. Brit. med. J. I, 1125.Google Scholar
  269. — Evidence concerning the endocrine function of the neurohypophysis and its nervous control. Colston Papers 8, 1.Google Scholar
  270. 1957. —Medicinal treatment: its aims and results. Second Gideon de Laune Lecture. Brit. med. J. II, 423.Google Scholar
  271. Percival Hartley, 1881–1957. Biog. Mems Fellows Roy. Soc. 3, 81.Google Scholar
  272. 1958. —Autobiographical sketch. Perspect. Biol. Med. 1, 125.PubMedGoogle Scholar
  273. — Pharmacy and modern therapeutics. Pharmacol. J. 127, 292.Google Scholar
  274. Arthur James Ewins, 1882–1958. Biog. Mems Fellows Roy. Soc. 4, 81.Google Scholar
  275. — Introductory Address to Symposium “Biochemical Aspects of Hypersensitivity”. Excerpta Medica Foundation, No 28, C 22.Google Scholar
  276. — Scientific Meeting of the Faculty of Anaesthetists on “Shock and allied phenomena”. Opening Speech. Ann. roy. Coll. Surg. 23, 265.Google Scholar
  277. 1959. — A defence of free learning by Lord Beveridge. Review by Sir Henry Dale in Discovery, Oct. 1959, p. 446.Google Scholar
  278. 1960. —The Medical Research Council: A memoir of its beginnings. New Sci. 7, 998.Google Scholar
  279. — Opening Address at IV European Congr. of Allergy. Acta allerg. (Kbh.) Suppl. VII, p. II.Google Scholar
  280. 1961. —Thomas Renton Elliott, 1877–1961. Biog. Mems Fellows Roy. Soc. 7, 53.Google Scholar
  281. — The relation of experimental research to medical knowledge and practice. King’s College Hosp. Gaz. 41, 37.Google Scholar
  282. 1961. —Some endocrinological memories. In Perspectives in biology, p. 19. Elsevier: Amsterdam-London-New York. Google Scholar
  283. 1962. —Otto Loewi, 1873–1961. Biog. Mems Fellows Roy. Soc. 8, 67.Google Scholar
  284. — Comparative aspects of neurohypophysial morphology and function. Symp. Zool. Soc. Lond. No 9, 179.Google Scholar
  285. 1963. —In Memoriam Otto Loewi. Ergebn. Physiol. 52, 1.PubMedGoogle Scholar
  286. — Pharmacology during the past sixty years. Ann. Rev. Pharmacol. 3, 1.Google Scholar
  287. — Award to Sir Henry Dale of the Schmiedeberg-Plakette. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 246, 1.Google Scholar
  288. — Medical Research Council Jubilee, 1913–1963: Fifty Years of Medical Research. Brit. med. J. II, 1279, 1287.Google Scholar
  289. — Foreword to Supplementary Volume of Heffter’s Handbuch der experimentellen Pharmakologie, Bd. 18, S. 26. Berlin-Göttingen-Heidelberg: Springer.Google Scholar
  290. 1964. —Sir Michael Foster, K. C. B., F. R. S. A Secretary of The Royal Society. In Not. Rec. Roy. Soc. Lond. 19, 10.Google Scholar

Copyright information

© Springer-Verlag 1971

Authors and Affiliations

  • H. O. Schild

There are no affiliations available

Personalised recommendations